The most common genetic alteration associated with GBM is the amplification of the epidermal growth factor receptor (EGFR), with a frequency of about 50% [2].The ligand-binding triggered the activation of amplified EGFR, resulting in enhanced downstream signaling controlling pleiotropic cellular responses, such as cell proliferation and survival [3]. Here, EGFR is linked to glioblastoma.